APA (7th ed.) Citation

Tan, Q., Kong, P., Chen, G., Chen, C., Mo, H., Huang, Y., . . . Wu, Y. (2025). Unveiling HJURP as a Biomarker of Poor Prognosis and Immunotherapy Resistance in Lung Adenocarcinoma: A Multicenter Study. Clinical Medicine Insights: Oncology, 19, 1. https://doi.org/10.1177/11795549251388872

Chicago Style (17th ed.) Citation

Tan, Qinglin, et al. "Unveiling HJURP as a Biomarker of Poor Prognosis and Immunotherapy Resistance in Lung Adenocarcinoma: A Multicenter Study." Clinical Medicine Insights: Oncology 19 (2025): 1. https://doi.org/10.1177/11795549251388872.

MLA (9th ed.) Citation

Tan, Qinglin, et al. "Unveiling HJURP as a Biomarker of Poor Prognosis and Immunotherapy Resistance in Lung Adenocarcinoma: A Multicenter Study." Clinical Medicine Insights: Oncology, vol. 19, 2025, p. 1, https://doi.org/10.1177/11795549251388872.